Effect of Smart Phone Application on the Individualized Management of Chinese Diabetic Patients

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

234 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-10-31

Study Completion Date

2016-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study was to explore a model suitable for the individualized diabetic management based on the mobile application coaching and demonstrate its effect among the diabetic mellitus population.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Study of Welltang- a Cell Phone-based Diabetes Management Application's Effect on Blood Glucose Control

NCT02313090

Diabetes Mellitus

COMPLETED NA

Mobile Phone Personalized Intervention for Diabetes

NCT02124408

Diabetes Mellitus

UNKNOWN NA

Integrated Diabetes Management Protocol Using Smartphone

NCT02362607

Diabetes

COMPLETED NA

Mobile Health and Wearable Devices for Diabetes Complication Management

NCT07129148

Diabetes Mellitus Type 2 Diabetes Mellitus Complications

NOT_YET_RECRUITING NA

A Smartphone-based Intervention for Diabetes Prevention in Overweight Chinese Adults With Pre-diabetes

NCT04875780

Pre-diabetes

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The enrolled patients will be randomly divided into three groups: group of online self management, group of online mutual management and the control group. The estimated sample size was 78 patients for each group. All the patients attend two follow-up visits at the hospital, after 3 and 6 months. The data will be collected by a full-time recorder and analyzed using specific statistical software. The enumeration data are analyzed by chi-square test, while the measurement data are analyzed by one-way ANOVA.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Diabetes Mellitus

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

online mutual management

The patients received the online coaching of a doctor and diabetes educator via smart phone based welltang app.

Group Type EXPERIMENTAL

Welltang App

Intervention Type DEVICE

This App is a large platform of individualized diabetic management

online self-management

The patients received the online coaching of a doctor alone via smart phone based welltang app.

Group Type EXPERIMENTAL

Welltang App

Intervention Type DEVICE

This App is a large platform of individualized diabetic management

hospital regular management

The patients received usual care and did not use smart phone.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Welltang App

This App is a large platform of individualized diabetic management

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Physician diagnosis of DM for more than 6 months;
* Glycated hemoglobin more than or equal to 8% within 3 months;
* Age:18-65 years.

Exclusion Criteria

* Insulin pump users;
* Pregnant;
* Active substance, alcohol, or drug abuser;
* Psychotic or schizophrenic under active care;
* Severe hearing or visual impairment and other complications;
* Drug users (such as glucocorticoid or thyroid hormone) 3 months before the enrollment;
* No smartphone access.

Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No